Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form
D-Scholarship @ Pitt Banner and Links to Homepage

Treatment of critically sized defects and enhancement of fracture healing in an osteoporotic animal model based on ex vivo gene therapy using BMP4

Rose, T and Peng, H and Usas, A and Josten, C and Fu, FH and Huard, J (2005) Treatment of critically sized defects and enhancement of fracture healing in an osteoporotic animal model based on ex vivo gene therapy using BMP4. Unfallchirurg, 108 (1). 25 - 34. ISSN 0177-5537

[img] Plain Text (licence)
Available under License : See the attached license file.
Download (1kB)

Abstract

Fractures in osteoporotic bones or segment defects are problematic bone lesions with a reduced biological capability of regeneration. We tested the hypothesis that cell-mediated ex vivo gene therapy to deliver BMP4 can heal critically sized defects and improve bone healing in osteoporotic rats. Primary muscle-derived cells were isolated from the hindlimb muscle of rats and retrovirally transduced to express bone morphogenic protein 4 (BMP4). The bone formation was evaluated following local application of these cells in critically sized defects and in fractures of osteoporotic bones. Radiographic ana lysis revealed bridging callus formation in a critically sized defect in all specimens using muscle-derived cells expressing BMP4 at 12 weeks. These findings were confirmed by histological evaluation, which revealed callus bone formation with good integration to the distal and proximal bone. Following treatment with muscle-derived cells expressing BMP4, the bone healing process in the osteoporotic bone was improved to the level similar to that of normal bone. The ex vivo gene therapy could be a promising tool for the treatment of osteoporotic fractures and critically sized defects. The reduced number of complications (nonunions, loss of reduction, and fragment dislocation), shortening of hospitalization period, and improvement of bone strength are decisive advocates for this treatment option.

Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Rose, T
Peng, H
Usas, A
Josten, C
Fu, FHffu@pitt.eduFFU
Huard, J
Date: 1 January 2005
Date Type: Publication
Journal or Publication Title: Unfallchirurg
Volume: 108
Number: 1
Page Range: 25 - 34
DOI or Unique Handle: 10.1007/s00113-004-0888-6
Schools and Programs: School of Medicine > Orthopaedic Surgery
Refereed: Yes
ISSN: 0177-5537
MeSH Headings: Animals; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins--genetics; Bone Morphogenetic Proteins--therapeutic use; Disease Models, Animal; Femoral Fractures--etiology; Femoral Fractures--genetics; Femoral Fractures--pathology; Femoral Fractures--therapy; Fracture Healing--drug effects; Genetic Therapy--methods; Osteoporosis--complications; Osteoporosis--genetics; Osteoporosis--pathology; Osteoporosis--therapy; Rats; Rats, Inbred F344; Treatment Outcome
PubMed ID: 15526179
Date Deposited: 09 Jun 2014 14:46
Last Modified: 04 Feb 2019 15:56
URI: http://d-scholarship.pitt.edu/id/eprint/21694

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com

Actions (login required)

View Item View Item